IT and IV Lentiviral Gene Therapy for X-ALD

Clinical trial NCT03727555 · RECRUITING

Trial details

NCT number: NCT03727555
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

X-linked Adrenoleukodystrophy

Start date: 2025-08-31
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.